• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).

作者信息

Pardanani A, Patnaik M M, Lasho T L, Mai M, Knudson R A, Finke C, Ketterling R P, McClure R F, Tefferi A

出版信息

Leukemia. 2010 Jul;24(7):1370-2. doi: 10.1038/leu.2010.98. Epub 2010 May 20.

DOI:10.1038/leu.2010.98
PMID:20485375
Abstract
摘要

相似文献

1
Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).高危骨髓增生异常综合征或伴有孤立性5号染色体长臂缺失的急性髓系白血病中的复发性异柠檬酸脱氢酶突变
Leukemia. 2010 Jul;24(7):1370-2. doi: 10.1038/leu.2010.98. Epub 2010 May 20.
2
Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.未发生 del[5q]的骨髓增生异常肿瘤患者应用来那度胺治疗的细胞遗传学和分子反应预测因子。
J Hematol Oncol. 2012 Mar 5;5:4. doi: 10.1186/1756-8722-5-4.
3
Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.5q 缺失的骨髓增生异常综合征和急性髓系白血病中 17p 缺失和 TP53 突变的发生率。
Genes Chromosomes Cancer. 2012 Dec;51(12):1086-92. doi: 10.1002/gcc.21993. Epub 2012 Aug 30.
4
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations.在 88 例连续患者中，WHO 定义的“孤立 del(5q) 的骨髓增生异常综合征”：生存数据、白血病转化率以及 JAK2、MPL 和 IDH 突变的发生率。
Leukemia. 2010 Jul;24(7):1283-9. doi: 10.1038/leu.2010.105. Epub 2010 May 20.
5
Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.孤立性 del(5q)在髓系恶性肿瘤中的临床病理和分子特征：143 例连续患者的分析。
Am J Hematol. 2011 May;86(5):393-8. doi: 10.1002/ajh.21984.
6
A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).一种新的复发性易位，t(5;11)(q35;p15.5)，与儿童急性髓系白血病中的5号染色体长臂缺失(del(5q))相关。英国癌症细胞遗传学组(UKCCG)。
Blood. 1999 Jul 15;94(2):773-80.
7
Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide.伴有del(5q)和JAK2 V617F突变的骨髓增生异常综合征在长期使用来那度胺治疗后转化为急性髓系白血病，并伴有额外的染色体异常。
Leuk Lymphoma. 2017 Oct;58(10):2511-2513. doi: 10.1080/10428194.2017.1295146. Epub 2017 Feb 28.
8
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.增加来那度胺剂量治疗伴有 5 号染色体异常的高危骨髓增生异常综合征和急性髓系白血病的临床疗效。
Haematologica. 2011 Jul;96(7):963-71. doi: 10.3324/haematol.2010.039669.
9
Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC).伴有骨髓增生异常相关改变的急性髓系白血病（AML-MRC）中罕见的四倍体伴5号染色体长臂大片段缺失。
Leuk Res. 2012 Apr;36(4):e68-70. doi: 10.1016/j.leukres.2011.12.014. Epub 2012 Jan 28.
10
Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients.94例骨髓增生异常综合征/急性髓系白血病患者5号染色体长臂缺失（del(5q)）的分子特征分析
Leukemia. 2012 Jul;26(7):1695-7. doi: 10.1038/leu.2012.9. Epub 2012 Jan 17.

引用本文的文献

1
IDH1/2 Mutations in Cancer: Unifying Insights and Unlocking Therapeutic Potential for Chondrosarcoma.癌症中的异柠檬酸脱氢酶1/2突变：对软骨肉瘤的统一见解与释放治疗潜力
Target Oncol. 2025 Jan;20(1):13-25. doi: 10.1007/s11523-024-01115-3. Epub 2024 Nov 15.
2
Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle.谷胱甘肽通过调节细胞周期促进维奈托克和阿扎胞苷对骨髓增生异常综合征难治性贫血的协同作用。
Exp Ther Med. 2023 Oct 26;26(6):574. doi: 10.3892/etm.2023.12274. eCollection 2023 Dec.
3
Myelodysplastic Syndrome: Diagnosis and Screening.
骨髓增生异常综合征：诊断与筛查
Diagnostics (Basel). 2022 Jun 29;12(7):1581. doi: 10.3390/diagnostics12071581.
4
Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy.评估ivosidenib用于治疗复发/难治性急性髓系白血病：设计、研发及治疗地位。
Onco Targets Ther. 2018 Dec 28;12:303-308. doi: 10.2147/OTT.S182443. eCollection 2019.
5
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone.低剂量化疗前使用地西他滨预处理可改善骨髓增生异常综合征-难治性贫血伴原始细胞过多型患者的预后：一项与单纯化疗对比的回顾性分析
J Cancer Res Clin Oncol. 2017 May;143(5):873-882. doi: 10.1007/s00432-016-2331-0. Epub 2017 Jan 20.
6
The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.异柠檬酸脱氢酶（IDH）突变在原发性血小板增多症和原发性骨髓纤维化中的临床意义
J Clin Med Res. 2016 Jan;8(1):29-39. doi: 10.14740/jocmr2405w. Epub 2015 Dec 3.
7
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression.骨髓增生异常综合征中的异柠檬酸脱氢酶1和异柠檬酸脱氢酶2突变及其在疾病进展中的作用。
Leukemia. 2016 Apr;30(4):980-4. doi: 10.1038/leu.2015.211. Epub 2015 Jul 31.
8
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft.5-氮杂胞苷可降低甲基化水平，促进分化，并在患者来源的异柠檬酸脱氢酶1（IDH1）突变型神经胶质瘤异种移植模型中诱导肿瘤消退。
Oncotarget. 2013 Oct;4(10):1737-47. doi: 10.18632/oncotarget.1408.
9
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.针对 del(5q) 骨髓增生异常综合征中常见的 25 个髓系疾病相关基因突变的靶向重测序分析。
Haematologica. 2013 Dec;98(12):1856-64. doi: 10.3324/haematol.2013.086686. Epub 2013 Jul 5.
10
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium.骨髓增殖性肿瘤中的表观遗传学效应突变和近期治疗进展：第 5 届国际后 ASH 研讨会会议录。
Blood Cancer J. 2011 Mar 4;1(3):e7. doi: 10.1038/bcj.2011.4.